Journal: Antimicrobial Agents and Chemotherapy
Article Title: Pharmacodynamics of Posaconazole in Experimental Invasive Pulmonary Aspergillosis: Utility of Serum Galactomannan as a Dynamic Endpoint of Antifungal Efficacy
doi: 10.1128/AAC.01574-20
Figure Lengend Snippet: Overview of the PK/PD study setup. Observed data and interventions are depicted against time. Dotted lines, start of posaconazole therapy in the treatment and prophylaxis groups (time the first dose was applied); dashed lines, time of inoculation with 1 × 108 conidia of A. fumigatus; black connected dots, GMI values; gray connected dots, posaconazole plasma concentrations.
Article Snippet: Aspergillus fumigatus (NIH isolate 4215 [ATCC MYA1163]) obtained from a fatal case of pulmonary aspergillosis was used in all experiments.
Techniques: